Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 01/03/2018.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Research Papers:
Clinicopathological impacts of c-Met overexpression in epithelial ovarian cancer: a meta-analysis and systemic review
Jung Han Kim1, Hyun Joo Jang2, Bum Jun Kim1,3 and Sung Ho Park4
1 Division of Hemato-Oncology, Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea
2 Department of Internal Medicine, Dongtan Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Gyeonggi-Do, Republic of Korea
3 Department of Internal Medicine, National Army Capital Hospital, The Armed Forces Medical Command, Gyeonggi-Do, Republic of Korea
4 Department of Obstetrics and Gynecology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Korea
Correspondence to:
Jung Han Kim, email: [email protected]
Sung Ho Park, email: [email protected]
Keywords: c-Met; ovarian cancer; prognosis; meta-analysis; review
Received: September 30, 2017 Accepted: November 13, 2017 Epub: January 03, 2018
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23889